LAVIPHARM S.A. NA EO 1 Financial Flexibility Index
LAVIPHARM S.A. NA EO 1 financial flexibility index. LAVIPHARM S.A. NA EO 1 (BXA0) has a Financial Flexibility Index of 0.20x as of December 2024. Free cash flow of €14.28 Million (operating CF €4.64 Million minus capex €9.64 Million) represents 0% of total liabilities (€72.52 Million). See BXA0 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of LAVIPHARM S.A. NA EO 1 (2021–2024)
Financial flexibility index of LAVIPHARM S.A. NA EO 1 from 2021 to 2024. Historical Financial Flexibility Index trend for LAVIPHARM S.A. NA EO 1 across 4 annual periods. Check earnings quality score of LAVIPHARM S.A. NA EO 1 to evaluate the quality of earnings relative to operating cash generation.
LAVIPHARM S.A. NA EO 1 Financial Flexibility Index by Year (2021–2024)
LAVIPHARM S.A. NA EO 1 financial flexibility index by year from 2021 to 2024. Year-by-year free cash flow to debt coverage for LAVIPHARM S.A. NA EO 1. For the full cash flow conversion analysis, see BXA0 cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.20x | €14.28 Million | €4.64 Million | €72.52 Million | ▲ +227.4% |
| 2023 | 0.06x | €4.33 Million | €284.00K | €72.02 Million | ▼ -88.6% |
| 2022 | 0.53x | €38.96 Million | €3.35 Million | €73.86 Million | ▲ +448.7% |
| 2021 | 0.10x | €6.03 Million | €4.11 Million | €62.68 Million | — |